New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer’s Disease | Presented at the 2025 Alzheimer’s Association International Conference
Demonstrates that the VeraBIND Tau assay accurately measures active tau pathology—a key biomarker of Alzheimer’s disease (AD) and other tauopathies—in individuals with and without cognitive impairment.
July 28, 2025
